Click here for free access to our latest coronavirus/COVID-19 research, commentary, and news.
Support nonprofit science journalism
Science’s extensive COVID-19 coverage is free to all readers. To support our nonprofit science journalism, please make a tax-deductible gift today.
Science visited Moderna in 2017 for an early look at its innovative RNA-based technology for drugs and vaccines